Hospital system Methodist Le Bonheur Healthcare (MLH) disclosed on Tuesday that it is the first hospital system globally to participate in a landmark study using a first-of-its-kind ZETO Instant EEG (electroencephalogram) in the midst of the unprecedented COVID-19 pandemic.
This new FDA-approved product, called zEEG from Zeto Inc, can be set up in less than five minutes and offers a more efficient and comfortable experience for the patient. The patient wears equipment that looks like a high-tech bicycle helmet. The electrodes do not need to be glued to the patient's scalp, do not leave any residue on the patient and there are no wires connected to an amplifier or computer.
Utilising the hospital's ZETO Instant EEG technology, the PPE and exposure time for healthcare workers is reduced significantly.The EEG tests are conducted to detect problems in the brain that may be associated with certain brain disorders including seizures, tumors or strokes. The setup and removal of a typical EEG test takes between 20-30 minutes.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval